Tectonic Therapeutic (TECX) Depreciation & Amortization (CF) (2017 - 2026)
Tectonic Therapeutic (TECX) reported Depreciation & Amortization (CF) of $304000.0 for Q1 2026, down 15.56% year-over-year from $360000.0 in Q1 2025, and down 8.71% quarter-over-quarter from $333000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $304000.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $304000.0, down 15.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 18.98% YoY), and the FY2025 annual result was $1.4 million, down 16.41% from the prior year.
- Depreciation & Amortization (CF) declined to $304000.0 in Q1 2026 per TECX's latest filing, from $333000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $508000.0 in Q4 2024 and troughed at $289000.0 in Q2 2023.
- A 5-year average of $359352.9 and a median of $342000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) jumped 37.11% in 2022, then slumped 34.45% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $335000.0 in 2022, then rose by 11.34% to $373000.0 in 2023, then surged by 36.19% to $508000.0 in 2024, then sank by 34.45% to $333000.0 in 2025, then declined by 8.71% to $304000.0 in 2026.
- Business Quant data shows TECX's Depreciation & Amortization (CF) at $304000.0 in Q1 2026, $333000.0 in Q4 2025, and $342000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 429,663.65 |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 304,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 304,000.00 |
| Mar 31, 2026 | 304,000.00 |
| Dec 31, 2025 | 333,000.00 |
| Dec 31, 2025 | 333,000.00 |
| Sep 30, 2025 | 342,000.00 |
| Sep 30, 2025 | 342,000.00 |
| Jun 30, 2025 | 340,000.00 |
| Jun 30, 2025 | 340,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Dec 31, 2024 | 508,000.00 |
| Dec 31, 2024 | 508,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 336,000.00 |
| Jun 30, 2024 | 336,000.00 |
| Mar 31, 2024 | 377,000.00 |
| Mar 31, 2024 | 377,000.00 |
| Dec 31, 2023 | 373,000.00 |
| Dec 31, 2023 | 373,000.00 |